AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Netherlands holding company reports increase in first quarter net sales.

Vaccine Weekly

| June 02, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JUN 2 - (NewsRx.com & NewsRx.net) -- Qiagen N.V. (QGENF) announced the results of operations for its first quarter and three-month period ended March 31, 2004.

The company reported that consolidated net sales for its first quarter 2004 increased 21% to $96.1 million, from $79.6 million for the same period in 2003.

Operating income for the quarter, including restructuring and relocation charges increased 12% to $18.1 million from $16.1 million in the comparable period in 2003, and net income for the quarter increased 4% to $11.4 million from $11.0 million in the same quarter of 2003.

Diluted earnings per share remained unchanged at $0.08, based on 148.8 million average shares and share equivalents outstanding in 2004 and 146.1 million average shares and share equivalents outstanding in 2003.

Excluding the effect of restructuring and relocation charges, operating income increased 8% to $19.0 million from $17.7 million in the comparable period in 2003. Net income excluding these items increased 14% to $12.0 million from $10.5 million and diluted earnings per share increased 14% to $0.08 compared to $0.07 in 2003.

The reported consolidated net sales exceeded the company's projections and diluted earnings per share were in line with the company's guidance for the first ...

Related articles from newspapers, magazines, journals, and more
QIAGEN Acquires Key Patent Portfolio in Nucleic Acid Separation for Research...
Press release article from: PR Newswire November 8, 1996 700+ words
...Technology Leadership in Nucleic Acid Separation AMSTERDAM...PRNewswire/ -- QIAGEN N.V., (Nasdaq...technology creates for QIAGEN's product line for nucleic acid purification in clinical...acquisition reflects QIAGEN's commitment to...
QIAGEN Launches the World's First CE-marked Nucleic Acid Purification Solution...
Press release article from: PR Newswire February 17, 2004 700+ words
...first CE-marked nucleic acid purification product...said Noel Doheny, QIAGEN's VP Solutions...instrumentation, synthetic nucleic acid products and related services. QIAGEN's products are...sequencing and genomics, nucleic acid-based molecular...and gene therapy. ...
QIAGEN Acquires the SAWADY Group in Japan Accretive Acquisition Accelerates...
Press release article from: PR Newswire April 24, 2001 700+ words
...expanding market. QIAGEN believes that the...market for synthetic nucleic acid products in 2000...revenues from synthetic nucleic acid products represented...approximately 10% of QIAGEN's year 2000 revenues...instrumentation, synthetic nucleic acid products and related ...
QIAGEN and Protedyne Enter Collaboration to Develop Nucleic Acid Purification...
Press release article from: PR Newswire June 14, 2004 700+ words
...ultra high-throughput nucleic acid purification procedures...s BioCube Systems. QIAGEN's proprietary nucleic acid sample preparation and...instrumentation, synthetic nucleic acid products and related services. QIAGEN's products are sold...
Pall and QIAGEN in Alliance to Develop and Market Nucleic Acid Handling and...
Press release article from: Business Wire October 29, 2001 700+ words
...combined with QIAGEN's leading nucleic acid separation and...technologies in nucleic acid separation and purification. QIAGEN has a history...technologies from QIAGEN's broad proprietary...create exciting nucleic acid separation and...
QIAGEN and Affymetrix to Develop and Commercialize Nucleic Acid Sample...
Press release article from: PR Newswire November 1, 1999 700+ words
...and strength of QIAGEN's technology...performance of nucleic acid analysis technologies...significantly facilitate nucleic acid analytics. QIAGEN N.V., a Netherlands...and handling, nucleic acid amplification...related services. QIAGEN's products...
Qiagen: Growth in Nucleic Acid Purification and Automation
Newspaper article from: Instrument Business Outlook May 15, 1998 700+ words
...primarily focused on nucleic acid handling, separation...each new technology, Qiagen has gradually leveraged...Teknika's patented nucleic acid purification technology...addition to expanding Qiagen's nucleic acid purification offering...
Frost & Sullivan Recognizes QIAGEN for Superior Product Innovation in the...
Press release article from: Business Wire October 22, 2003 700+ words
...entitled U.S. Nucleic Acid Isolation Markets identified QIAGEN as a market...industry analyst. "QIAGEN's leadership in the nucleic acid separations industry...instrumentation, synthetic nucleic acid products, and related services. QIAGEN's products...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA